Want to see CH:MEDX full AI Analyst Report?
Total Valuation
medmix AG has a market cap or net worth of CHF337.94M. The enterprise value is CHF610.90.
Market CapCHF337.94M
Enterprise ValueCHF610.90
Share Statistics
medmix AG has 41,262,370 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding41,262,370
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
medmix AG’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 2.61%.
Return on Equity (ROE)0.02
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)2.61%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee174.05K
Profits Per Employee2.49K
Employee Count2,574
Asset Turnover0.46
Inventory Turnover3.76
Valuation Ratios
The current PE Ratio of medmix AG is 3276.0. medmix AG’s PEG ratio is -0.37.
PE Ratio3276.0
PS Ratio1.02
PB Ratio1.08
Price to Fair Value1.08
Price to FCF13.76
Price to Operating Cash Flow5.62
PEG Ratio-0.37
Income Statement
In the last 12 months, medmix AG had revenue of 448.00M and earned 6.40M in profits. Earnings per share was 0.16.
Revenue448.00M
Gross Profit161.90M
Operating Income27.40M
Pretax Income9.00M
Net Income6.40M
EBITDA79.70M
Earnings Per Share (EPS)0.16
Cash Flow
In the last 12 months, operating cash flow was 59.30M and capital expenditures -27.60M, giving a free cash flow of 31.70M billion.
Operating Cash Flow59.30M
Free Cash Flow31.70M
Free Cash Flow per Share0.77
Dividends & Yields
medmix AG pays an annual dividend of CHF0.1, resulting in a dividend yield of 1.22%
Dividend Per ShareCHF0.1
Dividend Yield1.22%
Payout Ratio64.10%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.99
52-Week Price Change-33.22%
50-Day Moving Average8.43
200-Day Moving Average9.40
Relative Strength Index (RSI)47.99
Average Volume (3m)115.75K
Important Dates
medmix AG upcoming earnings date is Feb 23, 2027, TBA (Confirmed).
Last Earnings DateJul 23, 2026
Next Earnings DateFeb 23, 2027
Ex-Dividend Date―
Financial Position
medmix AG as a current ratio of 1.54, with Debt / Equity ratio of 75.15%
Current Ratio1.54
Quick Ratio1.10
Debt to Market Cap0.56
Net Debt to EBITDA2.82
Interest Coverage Ratio3.04
Taxes
In the past 12 months, medmix AG has paid 2.00M in taxes.
Income Tax2.00M
Effective Tax Rate0.22
Enterprise Valuation
medmix AG EV to EBITDA ratio is 8.57, with an EV/FCF ratio of 20.51.
EV to Sales1.52
EV to EBITDA8.57
EV to Free Cash Flow20.51
EV to Operating Cash Flow10.08
Balance Sheet
medmix AG has CHF111.30M in cash and marketable securities with CHF319.40M in debt, giving a net cash position of -CHF208.10M billion.
Cash & Marketable SecuritiesCHF111.30M
Total DebtCHF319.40M
Net Cash-CHF208.10M
Net Cash Per Share-CHF5.04
Tangible Book Value Per ShareCHF1.54
Margins
Gross margin is 36.73%, with operating margin of 6.12%, and net profit margin of 1.43%.
Gross Margin36.73%
Operating Margin6.12%
Pretax Margin2.01%
Net Profit Margin1.43%
EBITDA Margin17.79%
EBIT Margin6.12%
Analyst Forecast
The average price target for medmix AG is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-6.64%
EPS Growth Forecast―